Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model
Related Experiment Videos
Insights
Percutaneous Transluminal Coronary Angioplasty (PTCA) is significantly more cost-effective than Coronary Artery Bypass Grafting (CABG) for one-vessel coronary artery disease. PTCA offers substantial cost savings and shorter hospital stays compared to CABG.
Area of Science:
- Cardiovascular Medicine
- Health Economics
Background:
- Coronary Artery Disease (CAD) management involves revascularization procedures.
- Percutaneous Transluminal Coronary Angioplasty (PTCA) and Coronary Artery Bypass Grafting (CABG) are primary treatment options.
- Understanding the comparative cost-effectiveness is crucial for clinical and economic decision-making.
Purpose of the Study:
- To determine the relative costs of PTCA versus CABG.
- To evaluate the short-term cost-effectiveness of PTCA for one-vessel CAD compared to CABG.
Main Methods:
- A national study comparing PTCA and CABG procedures.
- Data collected from 186 PTCA cases and 175 CABG cases.
- Analysis of baseline clinical criteria, hospital stay duration, and procedural charges.
Main Results:
- Mean hospital stay was significantly shorter for PTCA (4 days) than CABG (12 days).
- Base charges for CABG ($15,580) were substantially higher than for PTCA ($5,315).
- PTCA demonstrated an 80% primary success rate with average savings of $7,149 per procedure.
Conclusions:
- PTCA is significantly more cost-effective than CABG for one-vessel CAD in the short term.
- The findings support PTCA as a financially advantageous revascularization strategy.
- Economic considerations favor PTCA, particularly in resource-limited settings.
Abstract:
A national study was carried out to determine the relative costs of PTCA and CABG. Baseline clinical criteria for the 2 groups were similar. Data were collected in 186 sets for the PTCA group and 175 sets for the CABG group. Male patients make up 81% of the PTCA group and 80% of the CABG group. Mean hospital stay was 12 +/- 5 days in the CABG group, compared with 4 +/- 2 days in the PTCA group (p less than 0.001). The base charges for hospital and professional components of the CABG procedure were $15,580 +/- $2,159, whereas the same charges for the PTCA procedure were $5,315 +/- $2,159 (p less than 0.001). With an 80% primary success rate, which was the group mean success rate, the average dollar savings per PTCA procedure would be $7,149, or $7,149,000 per 1,000 cases. Thus, PTCA for revascularization in 1-vessel CAD is significantly more cost-effective than CABG in the short term.